Surface Phenotype of Tumor Cells Determined by Flow Cytometry
| . | T Markers . | CD2 . | CD7 . | CD4 . | CD8 . | NK Markers . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | CD3 . | CD5 . | TCRαβ . | TCRγδ . | . | . | . | . | CD16 . | CD56 . | CD57 . | CD122 . |
| Case no. 1 (lymph node) | 0% | 0% | 0% | 0% | 100% | 100% | 0% | 100% | 3% | 96% | 0% | 97% |
| Case no. 2 (bone marrow) | 2% | 2% | 4% | 1% | 22% | 98% | 85% | 2% | 1% | 96% | 3% | 0% |
| Case no. 3 (lymph node) | 2% | 2% | 2% | 0% | 98% | 3% | 1% | 1% | 90% | 97% | 0% | 94% |
| . | T Markers . | CD2 . | CD7 . | CD4 . | CD8 . | NK Markers . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | CD3 . | CD5 . | TCRαβ . | TCRγδ . | . | . | . | . | CD16 . | CD56 . | CD57 . | CD122 . |
| Case no. 1 (lymph node) | 0% | 0% | 0% | 0% | 100% | 100% | 0% | 100% | 3% | 96% | 0% | 97% |
| Case no. 2 (bone marrow) | 2% | 2% | 4% | 1% | 22% | 98% | 85% | 2% | 1% | 96% | 3% | 0% |
| Case no. 3 (lymph node) | 2% | 2% | 2% | 0% | 98% | 3% | 1% | 1% | 90% | 97% | 0% | 94% |